Andrew Hykes - 16 May 2023 Form 4 Insider Report for Inari Medical, Inc.

Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Issuer symbol
N/A
Transactions as of
16 May 2023
Net transactions value
-$2,567,711
Form type
4
Filing time
18 May 2023, 20:16:46 UTC
Previous filing
04 Apr 2023
Next filing
05 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale $57,972 -818 -0.15% $70.87 549,466 16 May 2023 Direct F1, F2
transaction NARI Common Stock Sale $1,200,892 -16,945 -3.1% $70.87 532,521 16 May 2023 Direct F1, F3
transaction NARI Common Stock Sale $10,843 -153 -0.03% $70.87 532,368 16 May 2023 Direct F1
transaction NARI Common Stock Sale $1,112,506 -16,079 -3% $69.19 516,289 17 May 2023 Direct F1, F4
transaction NARI Common Stock Sale $181,970 -2,630 -0.51% $69.19 513,659 17 May 2023 Direct F1, F5
transaction NARI Common Stock Sale $3,529 -51 -0.01% $69.19 513,608 17 May 2023 Direct F1
holding NARI Common Stock 1,550 16 May 2023 By Child 1
holding NARI Common Stock 1,550 16 May 2023 By Child 2
holding NARI Common Stock 1,550 16 May 2023 By Child 3
holding NARI Common Stock 1,000 16 May 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $69.07 to $69.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $70.27 to $71.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $69.07 to $69.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $70.27 to $71.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.